Acuitas provides delivery solutions for molecular therapeutics using lipid nanoparticles (LNP).
Acuitas Therapeutics was founded in 2009 by Thomas Madden.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range.
Acuitas Therapeutics may be growing as evidenced by its recent settlement of a lawsuit over COVID-19 vaccine patent rights, which could indicate a resolution of disputes that may have previously hindered its operations. Additionally, the company has entered into a strategic partnership with Aldevron, which could potentially expand its operational capabilities and market reach. Furthermore, the global market for lipid nanoparticle raw materials, which are relevant to Acuitas Therapeutics' field of operation, is projected to grow, suggesting a favorable market environment for the company's services.
“Acuitas is the global leader in the development of lipid nanoparticle delivery systems. Learn more about the real world applications of our unmatched LNP platform.” acuitastx.com
Acuitas Therapeutics is a biotechnology company, with 11-50 employees, founded in 2009. Its website drew about 930 visits in the latest month measured and its founder is Thomas Madden.
11-50 employees · agadabio.com
11-50 employees · 8five8tx.com
11-50 employees · abferopharmaceuticals.com
11-50 employees · aatbio.com
11-50 employees · actx.com
11-50 employees · accugenlabs.com
11-50 employees · abalonebio.com
11-50 employees · activmedresearch.com
11-50 employees · 4p-pharma.com
11-50 employees · asip.org
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.